<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33203755</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2150-7511</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>17</Day></PubDate></JournalIssue><Title>mBio</Title><ISOAbbreviation>mBio</ISOAbbreviation></Journal><ArticleTitle>The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e02540-20</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/mBio.02540-20</ELocationID><Abstract><AbstractText>Enteroviruses infect gastrointestinal epithelium cells, cause multiple human diseases, and present public health risks worldwide. However, the mechanisms underlying host immune responses in intestinal mucosa against the early enterovirus infections remain elusive. Here, we showed that human enteroviruses including enterovirus 71 (EV71), coxsackievirus B3 (CVB3), and poliovirus 1 (PV1) predominantly induce type III interferons (IFN-&#x3bb;1 and IFN-&#x3bb;2/3), rather than type I interferons (IFN-&#x3b1; and IFN-&#x3b2;), in cultured human normal and cancerous intestine epithelial cells (IECs), mouse intestine tissues, and human clinical intestine specimens. Mechanistic studies demonstrated that IFN-&#x3bb; production is induced upon enterovirus infection through the Toll-like receptor 3/interferon regulatory factor 1 (TLR3/IRF1) signaling pathway in IECs. In turn, the supplementation of IFN-&#x3bb; subsequently induces intrinsically antiviral responses against enterovirus replication. Notably, intraperitoneal injection in neonatal C57BL/6J mice with mouse recombinant IFN-&#x3bb;2 protein represses EV71 replication and protects mice from viral lethal effects. Altogether, these results revealed a distinct mechanism by which the host elicited immune responses against enterovirus infections in intestine through activating the TLR3/IRF1/type III IFN axis. The new findings would provide an antiviral strategy for the prevention and treatment of enterovirus infections and associated diseases.<b>IMPORTANCE</b> Enterovirus infections are significant sources of human diseases and public health risks worldwide, but little is known about the mechanism of innate immune response in host intestine epithelial surface during the viral replication. We reported the epithelial immune response in cultured human normal and cancerous cells (IECs), mouse tissues, and human clinical intestine specimens following infection with enterovirus 71. The results mechanistically revealed type III interferons (IFN-&#x3bb;1 and IFN-&#x3bb;2/3), rather than type I interferons (IFN-&#x3b1; and IFN-&#x3b2;), as the dominant production through TLR3/IRF1 signaling upon multiple human enterovirus infection, including enterovirus 71 (EV71), coxsackievirus B3 (CVB3), and poliovirus 1 (PV1). IFN-&#x3bb; subsequently induced antiviral activity against enterovirus replication <i>in vitro</i> and <i>in vivo.</i> These studies uncovered the role of the novel process of type III IFN production involved in the TLR3/IRF1 pathway in host intestine upon enterovirus infection, which highlighted a regulatory manner of antiviral defense in intestine during enterovirus infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Su et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Su</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shereen</LastName><ForeName>Muhammad Adnan</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zeng</LastName><ForeName>Xiaofeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Forensic Medicine, Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yicong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruan</LastName><ForeName>Zhihui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yongkui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Weiyong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yingle</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Kailang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-1142-2845</Identifier><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China zhluo18@jnu.edu.cn jwu@whu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jianguo</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8326-2895</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China zhluo18@jnu.edu.cn jwu@whu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>mBio</MedlineTA><NlmUniqueID>101519231</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050856">Interferon Regulatory Factor-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494258">Irf1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C519703">TLR3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051196">Toll-Like Receptor 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000095022">Interferon Lambda</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050856" MajorTopicYN="N">Interferon Regulatory Factor-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007422" MajorTopicYN="N">Intestines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051196" MajorTopicYN="N">Toll-Like Receptor 3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095022" MajorTopicYN="N">Interferon Lambda</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Toll-like receptor 3</Keyword><Keyword MajorTopicYN="N">coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">enterovirus infection</Keyword><Keyword MajorTopicYN="N">interferon regulatory factor 1</Keyword><Keyword MajorTopicYN="N">interferon-stimulated genes</Keyword><Keyword MajorTopicYN="N">intestine</Keyword><Keyword MajorTopicYN="N">intestine epithelial cells</Keyword><Keyword MajorTopicYN="N">neonatal C57BL/6J mice</Keyword><Keyword MajorTopicYN="N">poliovirus 1</Keyword><Keyword MajorTopicYN="N">type III interferons</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>18</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33203755</ArticleId><ArticleId IdType="pmc">PMC7683398</ArticleId><ArticleId IdType="doi">10.1128/mBio.02540-20</ArticleId><ArticleId IdType="pii">mBio.02540-20</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pons-Salort M, Grassly NC. 2018. Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses. Science 361:800&#x2013;803. doi:10.1126/science.aat6777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat6777</ArticleId><ArticleId IdType="pmc">PMC6559928</ArticleId><ArticleId IdType="pubmed">30139872</ArticleId></ArticleIdList></Reference><Reference><Citation>Black S, Bradley C, Lai FY, Shenoy S, Bandi S, Allen DJ, Tang JW. 2019. Comparing the clinical severity of disease caused by enteroviruses and human parechoviruses in neonates and infants. Pediatr Infect Dis J 38:e36&#x2013;e38. doi:10.1097/INF.0000000000002145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002145</ArticleId><ArticleId IdType="pubmed">30001232</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells AI, Coyne CB. 2019. Enteroviruses: a gut-wrenching game of entry, detection, and evasion. Viruses 11:460. doi:10.3390/v11050460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11050460</ArticleId><ArticleId IdType="pmc">PMC6563291</ArticleId><ArticleId IdType="pubmed">31117206</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang PN, Shih SR. 2014. Update on enterovirus 71 infection. Curr Opin Virol 5:98&#x2013;104. doi:10.1016/j.coviro.2014.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.03.007</ArticleId><ArticleId IdType="pubmed">24727707</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Chang Z, Wu P, Liao Q, Liu F, Zheng Y, Luo L, Zhou Y, Chen Q, Yu S, Guo C, Chen Z, Long L, Zhao S, Yang B, Yu H, Cowling BJ. 2018. Emerging enteroviruses causing hand, foot and mouth disease, China, 2010&#x2013;2016. Emerg Infect Dis 24:1902&#x2013;1906. doi:10.3201/eid2410.171953.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2410.171953</ArticleId><ArticleId IdType="pmc">PMC6154135</ArticleId><ArticleId IdType="pubmed">30226172</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye L, Schnepf D, Staeheli P. 2019. Interferon-lambda orchestrates innate and adaptive mucosal immune responses. Nat Rev Immunol 19:614&#x2013;625. doi:10.1038/s41577-019-0182-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0182-z</ArticleId><ArticleId IdType="pubmed">31201377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingle H, Peterson ST, Baldridge MT. 2018. Distinct effects of type I and III interferons on enteric viruses. Viruses 10:46. doi:10.3390/v10010046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10010046</ArticleId><ArticleId IdType="pmc">PMC5795459</ArticleId><ArticleId IdType="pubmed">29361691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JD, Feng N, Sen A, Balan M, Tseng HC, McElrath C, Smirnov SV, Peng J, Yasukawa LL, Durbin RK, Durbin JE, Greenberg HB, Kotenko SV. 2016. Distinct roles of type I and type III interferons in intestinal immunity to homologous and heterologous rotavirus infections. PLoS Pathog 12:e1005600. doi:10.1371/journal.ppat.1005600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005600</ArticleId><ArticleId IdType="pmc">PMC4851417</ArticleId><ArticleId IdType="pubmed">27128797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming OJ, Terczy&#x144;ska-Dyla E, Vieyres G, Dijkman R, J&#xf8;rgensen SE, Akhtar H, Siupka P, Pietschmann T, Thiel V, Hartmann R. 2013. Interferon lambda 4 signals via the IFNlambda receptor to regulate antiviral activity against HCV and coronaviruses. EMBO J 32:3055&#x2013;3065. doi:10.1038/emboj.2013.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.232</ArticleId><ArticleId IdType="pmc">PMC3844954</ArticleId><ArticleId IdType="pubmed">24169568</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear HM, Nice TJ, Diamond MS. 2015. Interferon-lambda: immune functions at barrier surfaces and beyond. Immunity 43:15&#x2013;28. doi:10.1016/j.immuni.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4527169</ArticleId><ArticleId IdType="pubmed">26200010</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear HM, Schoggins JW, Diamond MS. 2019. Shared and distinct functions of type I and type III interferons. Immunity 50:907&#x2013;923. doi:10.1016/j.immuni.2019.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.03.025</ArticleId><ArticleId IdType="pmc">PMC6839410</ArticleId><ArticleId IdType="pubmed">30995506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesev EV, LeDesma RA, Ploss A. 2019. Decoding type I and III interferon signalling during viral infection. Nat Microbiol 4:914&#x2013;924. doi:10.1038/s41564-019-0421-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0421-x</ArticleId><ArticleId IdType="pmc">PMC6554024</ArticleId><ArticleId IdType="pubmed">30936491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding S, Robek MD. 2014. Peroxisomal MAVS activates IRF1-mediated IFN-lambda production. Nat Immunol 15:700&#x2013;701. doi:10.1038/ni.2924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2924</ArticleId><ArticleId IdType="pubmed">25045870</ArticleId></ArticleIdList></Reference><Reference><Citation>Odendall C, Dixit E, Stavru F, Bierne H, Franz KM, Durbin AF, Boulant S, Gehrke L, Cossart P, Kagan JC. 2014. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat Immunol 15:717&#x2013;726. doi:10.1038/ni.2915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2915</ArticleId><ArticleId IdType="pmc">PMC4106986</ArticleId><ArticleId IdType="pubmed">24952503</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel R, Eskdale J, Gallagher G. 2011. Regulation of IFN-lambda1 promoter activity (IFN-lambda1/IL-29) in human airway epithelial cells. J Immunol 187:5636&#x2013;5644. doi:10.4049/jimmunol.1003988.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1003988</ArticleId><ArticleId IdType="pubmed">22058416</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulverer JE, Rand U, Lienenklaus S, Kugel D, Zietara N, Kochs G, Naumann R, Weiss S, Staeheli P, Hauser H, Koster M. 2010. Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol 84:8626&#x2013;8638. doi:10.1128/JVI.00303-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00303-10</ArticleId><ArticleId IdType="pmc">PMC2919002</ArticleId><ArticleId IdType="pubmed">20573823</ArticleId></ArticleIdList></Reference><Reference><Citation>Forero A, Ozarkar S, Li H, Lee CH, Hemann EA, Nadjsombati MS, Hendricks MR, So L, Green R, Roy CN, Sarkar SN, von Moltke J, Anderson SK, Gale M, Savan R. 2019. Differential activation of the transcription factor IRF1 underlies the distinct immune responses elicited by type I and type III interferons. Immunity 51:451&#x2013;464.e6. doi:10.1016/j.immuni.2019.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.07.007</ArticleId><ArticleId IdType="pmc">PMC7447158</ArticleId><ArticleId IdType="pubmed">31471108</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinkhammer J, Schnepf D, Ye L, Schwaderlapp M, Gad HH, Hartmann R, Garcin D, Mahlakoiv T, Staeheli P. 2018. IFN-lambda prevents influenza virus spread from the upper airways to the lungs and limits virus transmission. Elife 7:e33354. doi:10.7554/eLife.33354.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.33354</ArticleId><ArticleId IdType="pmc">PMC5953542</ArticleId><ArticleId IdType="pubmed">29651984</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Tian B, Sun H, Garofalo RP, Brasier AR. 2017. Epigenetic silencing of IRF1 dysregulates type III interferon responses to respiratory virus infection in epithelial to mesenchymal transition. Nat Microbiol 2:17086. doi:10.1038/nmicrobiol.2017.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmicrobiol.2017.86</ArticleId><ArticleId IdType="pmc">PMC5501188</ArticleId><ArticleId IdType="pubmed">28581456</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond CG, Bolock AM, Ma C, Luke CJ, Good M, Coyne CB. 2017. Enteroviruses infect human enteroids and induce antiviral signaling in a cell lineage-specific manner. Proc Natl Acad Sci U S A 114:1672&#x2013;1677. doi:10.1073/pnas.1617363114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1617363114</ArticleId><ArticleId IdType="pmc">PMC5320971</ArticleId><ArticleId IdType="pubmed">28137842</ArticleId></ArticleIdList></Reference><Reference><Citation>Good C, Wells AI, Coyne CB. 2019. Type III interferon signaling restricts enterovirus 71 infection of goblet cells. Sci Adv 5:eaau4255. doi:10.1126/sciadv.aau4255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau4255</ArticleId><ArticleId IdType="pmc">PMC6402847</ArticleId><ArticleId IdType="pubmed">30854425</ArticleId></ArticleIdList></Reference><Reference><Citation>Nice TJ, Baldridge MT, McCune BT, Norman JM, Lazear HM, Artyomov M, Diamond MS, Virgin HW. 2015. Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity. Science 347:269&#x2013;273. doi:10.1126/science.1258100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1258100</ArticleId><ArticleId IdType="pmc">PMC4398891</ArticleId><ArticleId IdType="pubmed">25431489</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear HM, Daniels BP, Pinto AK, Huang AC, Vick SC, Doyle SE, Gale M, Jr, Klein RS, Diamond MS. 2015. Interferon-lambda restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci Transl Med 7:284ra59. doi:10.1126/scitranslmed.aaa4304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa4304</ArticleId><ArticleId IdType="pmc">PMC4435724</ArticleId><ArticleId IdType="pubmed">25904743</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X. 2016. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat Rev Immunol 16:35&#x2013;50. doi:10.1038/nri.2015.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2015.8</ArticleId><ArticleId IdType="pubmed">26711677</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugge M, Bergstrom B, Eide OK, Solli H, Kjonstad IF, Stenvik J, Espevik T, Nilsen NJ. 2017. Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness. J Biol Chem 292:15408&#x2013;15425. doi:10.1074/jbc.M117.784090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.784090</ArticleId><ArticleId IdType="pmc">PMC5602399</ArticleId><ArticleId IdType="pubmed">28717003</ArticleId></ArticleIdList></Reference><Reference><Citation>Pott J, Mahlakoiv T, Mordstein M, Duerr CU, Michiels T, Stockinger S, Staeheli P, Hornef MW. 2011. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A 108:7944&#x2013;7949. doi:10.1073/pnas.1100552108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1100552108</ArticleId><ArticleId IdType="pmc">PMC3093475</ArticleId><ArticleId IdType="pubmed">21518880</ArticleId></ArticleIdList></Reference><Reference><Citation>Pott J, Stockinger S, Torow N, Smoczek A, Lindner C, McInerney G, Backhed F, Baumann U, Pabst O, Bleich A, Hornef MW. 2012. Age-dependent TLR3 expression of the intestinal epithelium contributes to rotavirus susceptibility. PLoS Pathog 8:e1002670. doi:10.1371/journal.ppat.1002670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002670</ArticleId><ArticleId IdType="pmc">PMC3343008</ArticleId><ArticleId IdType="pubmed">22570612</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Ji L, Yuan X, Jin Y, Cardona CJ, Xing Z. 2016. Differential regulation of TLR signaling on the induction of antiviral interferons in human intestinal epithelial cells infected with enterovirus 71. PLoS One 11:e0152177. doi:10.1371/journal.pone.0152177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0152177</ArticleId><ArticleId IdType="pmc">PMC4805281</ArticleId><ArticleId IdType="pubmed">27007979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren G, Cui K, Zhang Z, Zhao K. 2015. Division of labor between IRF1 and IRF2 in regulating different stages of transcriptional activation in cellular antiviral activities. Cell Biosci 5:17. doi:10.1186/s13578-015-0007-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-015-0007-0</ArticleId><ArticleId IdType="pmc">PMC4424430</ArticleId><ArticleId IdType="pubmed">25960866</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Jiang Z, Acosta-Rodriguez VA, Berger M, Du X, Choi JH, Wang J, Wang KW, Kilaru GK, Mohawk JA, Quan J, Scott L, Hildebrand S, Li X, Tang M, Zhan X, Murray AR, La Vine D, Moresco EMY, Takahashi JS, Beutler B. 2017. HCFC2 is needed for IRF1- and IRF2-dependent Tlr3 transcription and for survival during viral infections. J Exp Med 214:3263&#x2013;3277. doi:10.1084/jem.20161630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20161630</ArticleId><ArticleId IdType="pmc">PMC5679162</ArticleId><ArticleId IdType="pubmed">28970238</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda D, Gjinaj E, Bachu M, Squire E, Novatt H, Ozato K, Rabin RL. 2019. IRF1 maintains optimal constitutive expression of antiviral genes and regulates the early antiviral response. Front Immunol 10:1019. doi:10.3389/fimmu.2019.01019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01019</ArticleId><ArticleId IdType="pmc">PMC6529937</ArticleId><ArticleId IdType="pubmed">31156620</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SL, Pan H, Liu P, Amer S, Chan TC, Zhan J, Huo X, Liu Y, Teng Z, Wang L, Zhuang H. 2015. Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014. Rev Med Virol 25:115&#x2013;128. doi:10.1002/rmv.1827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1827</ArticleId><ArticleId IdType="pubmed">25704797</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, Su R, Wang W, Liang Y, Zeng X, Shereen MA, Bashir N, Zhang Q, Zhao L, Wu K, Liu Y, Wu J. 2019. EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production. PLoS Pathog 15:e1008142. doi:10.1371/journal.ppat.1008142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008142</ArticleId><ArticleId IdType="pmc">PMC6932824</ArticleId><ArticleId IdType="pubmed">31730654</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia T, Konno H, Ahn J, Barber GN. 2016. Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis. Cell Rep 14:282&#x2013;297. doi:10.1016/j.celrep.2015.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.12.029</ArticleId><ArticleId IdType="pmc">PMC4845097</ArticleId><ArticleId IdType="pubmed">26748708</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz S, Haehnel V, Karaghiosoff M, Schwarzfischer L, Muller M, Krause SW, Rehli M. 2003. Species-specific regulation of Toll-like receptor 3 genes in men and mice. J Biol Chem 278:21502&#x2013;21509. doi:10.1074/jbc.M301476200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M301476200</ArticleId><ArticleId IdType="pubmed">12672806</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Foo DG, Trasti SL, Tan EL, Alonso S. 2011. Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J Virol 85:3067&#x2013;3076. doi:10.1128/JVI.01779-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01779-10</ArticleId><ArticleId IdType="pmc">PMC3067852</ArticleId><ArticleId IdType="pubmed">21228224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge M, Luo Z, Qiao Z, Zhou Y, Cheng X, Geng Q, Cai Y, Wan P, Xiong Y, Liu F, Wu K, Liu Y, Wu J. 2017. HERP binds TBK1 to activate innate immunity and repress virus replication in response to endoplasmic reticulum stress. J Immunol 199:3280&#x2013;3292. doi:10.4049/jimmunol.1700376.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700376</ArticleId><ArticleId IdType="pubmed">28954889</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2004. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 78:7916&#x2013;7924. doi:10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown EM, Kenny DJ, Xavier RJ. 2019. Gut microbiota regulation of T cells during inflammation and autoimmunity. Annu Rev Immunol 37:599&#x2013;624. doi:10.1146/annurev-immunol-042718-041841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042718-041841</ArticleId><ArticleId IdType="pubmed">31026411</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson LW, Artis D. 2014. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 14:141&#x2013;153. doi:10.1038/nri3608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3608</ArticleId><ArticleId IdType="pubmed">24566914</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini V, Morantz EK, Browne H, Ettayebi K, Zeng XL, Atmar RL, Estes MK, Vinje J. 2018. Human norovirus replication in human intestinal enteroids as model to evaluate virus inactivation. Emerg Infect Dis 24:1453&#x2013;1464. doi:10.3201/eid2408.180126.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2408.180126</ArticleId><ArticleId IdType="pmc">PMC6056096</ArticleId><ArticleId IdType="pubmed">30014841</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettayebi K, Crawford SE, Murakami K, Broughman JR, Karandikar U, Tenge VR, Neill FH, Blutt SE, Zeng XL, Qu L, Kou B, Opekun AR, Burrin D, Graham DY, Ramani S, Atmar RL, Estes MK. 2016. Replication of human noroviruses in stem cell-derived human enteroids. Science 353:1387&#x2013;1393. doi:10.1126/science.aaf5211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf5211</ArticleId><ArticleId IdType="pmc">PMC5305121</ArticleId><ArticleId IdType="pubmed">27562956</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkbeiner SR, Zeng XL, Utama B, Atmar RL, Shroyer NF, Estes MK. 2012. Stem cell-derived human intestinal organoids as an infection model for rotaviruses. mBio 3:e00159-12. doi:10.1128/mBio.00159-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00159-12</ArticleId><ArticleId IdType="pmc">PMC3398537</ArticleId><ArticleId IdType="pubmed">22761392</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena K, Blutt SE, Ettayebi K, Zeng XL, Broughman JR, Crawford SE, Karandikar UC, Sastri NP, Conner ME, Opekun AR, Graham DY, Qureshi W, Sherman V, Foulke-Abel J, In J, Kovbasnjuk O, Zachos NC, Donowitz M, Estes MK. 2016. Human intestinal enteroids: a new model to study human rotavirus infection, host restriction, and pathophysiology. J Virol 90:43&#x2013;56. doi:10.1128/JVI.01930-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01930-15</ArticleId><ArticleId IdType="pmc">PMC4702582</ArticleId><ArticleId IdType="pubmed">26446608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373&#x2013;384. doi:10.1038/ni.1863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1863</ArticleId><ArticleId IdType="pubmed">20404851</ArticleId></ArticleIdList></Reference><Reference><Citation>Otte JM, Cario E, Podolsky DK. 2004. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126:1054&#x2013;1070. doi:10.1053/j.gastro.2004.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2004.01.007</ArticleId><ArticleId IdType="pubmed">15057745</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbin RK, Kotenko SV, Durbin JE. 2013. Interferon induction and function at the mucosal surface. Immunol Rev 255:25&#x2013;39. doi:10.1111/imr.12101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12101</ArticleId><ArticleId IdType="pmc">PMC5972370</ArticleId><ArticleId IdType="pubmed">23947345</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ML, Lee YP, Wang YF, Lei HY, Liu CC, Wang SM, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2005. Type I interferons protect mice against enterovirus 71 infection. J Gen Virol 86:3263&#x2013;3269. doi:10.1099/vir.0.81195-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81195-0</ArticleId><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Pervolaraki K, Rastgou Talemi S, Albrecht D, Bormann F, Bamford C, Mendoza JL, Garcia KC, McLauchlan J, Hofer T, Stanifer ML, Boulant S. 2018. Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance. PLoS Pathog 14:e1007420. doi:10.1371/journal.ppat.1007420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007420</ArticleId><ArticleId IdType="pmc">PMC6287881</ArticleId><ArticleId IdType="pubmed">30485383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4:e1000017. doi:10.1371/journal.ppat.1000017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000017</ArticleId><ArticleId IdType="pmc">PMC2265414</ArticleId><ArticleId IdType="pubmed">18369468</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahlakoiv T, Hernandez P, Gronke K, Diefenbach A, Staeheli P. 2015. Leukocyte-derived IFN-alpha/beta and epithelial IFN-lambda constitute a compartmentalized mucosal defense system that restricts enteric virus infections. PLoS Pathog 11:e1004782. doi:10.1371/journal.ppat.1004782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004782</ArticleId><ArticleId IdType="pmc">PMC4388470</ArticleId><ArticleId IdType="pubmed">25849543</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Z, Sheridan BS. 2018. Isolating lymphocytes from the mouse small intestinal immune system. J Vis Exp (132):57281. doi:10.3791/57281.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/57281</ArticleId><ArticleId IdType="pmc">PMC5931411</ArticleId><ArticleId IdType="pubmed">29553537</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson CM, O&#x2019;Brien A, Albers TM, Simon MA, Clifford CB, Pritchett-Corning KR. 2011. Diagnostic necropsy and selected tissue and sample collection in rats and mice. J Vis Exp (54):2966. doi:10.3791/2966.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/2966</ArticleId><ArticleId IdType="pmc">PMC3211129</ArticleId><ArticleId IdType="pubmed">21847084</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, Ge M, Chen J, Geng Q, Tian M, Qiao Z, Bai L, Zhang Q, Zhu C, Xiong Y, Wu K, Liu F, Liu Y, Wu J. 2017. HRS plays an important role for TLR7 signaling to orchestrate inflammation and innate immunity upon EV71 infection. PLoS Pathog 13:e1006585. doi:10.1371/journal.ppat.1006585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006585</ArticleId><ArticleId IdType="pmc">PMC5595348</ArticleId><ArticleId IdType="pubmed">28854257</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, Dong X, Li Y, Zhang Q, Kim C, Song Y, Kang L, Liu Y, Wu K, Wu J. 2014. PolyC-binding protein 1 interacts with 5&#x2032;-untranslated region of enterovirus 71 RNA in membrane-associated complex to facilitate viral replication. PLoS One 9:e87491. doi:10.1371/journal.pone.0087491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087491</ArticleId><ArticleId IdType="pmc">PMC3906175</ArticleId><ArticleId IdType="pubmed">24489926</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, Lee HK, Shen C, Cojocaru G, Shenouda S, Kagnoff M, Eckmann L, Ben-Neriah Y, Raz E. 2006. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8:1327&#x2013;1336. doi:10.1038/ncb1500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1500</ArticleId><ArticleId IdType="pubmed">17128265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>